Epigenetic therapy targeting bone marrow mesenchymal stem cells for age-related bone diseases
Authors:
Open Access
- 16 May 2022
- journal article
- review article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 13 (1) , 1-17
Abstract
As global aging accelerates, the prevention and treatment of age-related bone diseases are becoming a critical issue. In the process of senescence, bone marrow mesenchymal stem cells (BMSCs) gradually lose the capability of self-renewal and functional differentiation, resulting in impairment of bone tissue regeneration and disorder of bone tissue homeostasis. Alteration in epigenetic modification is an essential factor of BMSC dysfunction during aging. Its transferability and reversibility provide the possibility to combat BMSC aging by reversing age-related modifications. Emerging evidence demonstrates that epigenetic therapy based on aberrant epigenetic modifications could alleviate the senescence and dysfunction of stem cells. This review summarizes potential therapeutic targets for BMSC aging, introduces some potential approaches to alleviating BMSC aging, and analyzes its prospect in the clinical application of age-related bone diseases.Keywords
Funding Information
- National Natural Science Foundation of China (81600912, 82071092)
- Key Project of Sichuan province (2020YFS0177, 2019YFS0311)
- Fundamental Research Funds for the Central Universities (YJ201878)
This publication has 149 references indexed in Scilit:
- Vorinostat, a HDAC inhibitor, showed anti-osteoarthritic activities through inhibition of iNOS and MMP expression, p38 and ERK phosphorylation and blocking NF-κB nuclear translocationInternational Immunopharmacology, 2013
- Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma CellsPLOS ONE, 2013
- Histone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcriptionJournal of Bone and Mineral Research, 2011
- DNA methylation pattern changes upon long‐term culture and aging of human mesenchymal stromal cellsAging Cell, 2010
- Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytesBMC Musculoskeletal Disorders, 2009
- Integrative MicroRNA and Proteomic Approaches Identify Novel Osteoarthritis Genes and Their Collaborative Metabolic and Inflammatory NetworksPLOS ONE, 2008
- Mesenchymal stem cells in health and diseaseNature Reviews Immunology, 2008
- Cellular senescence: when bad things happen to good cellsNature Reviews Molecular Cell Biology, 2007
- Mechanisms of gene silencing by double-stranded RNANature, 2004
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999